CKPT - Checkpoint Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
4,714
3,506
1,725
2,570
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
26,016
33,654
19,081
20,267
Selling General and Administrative
6,583
6,592
5,419
4,467
Total Operating Expenses
32,599
40,246
24,500
24,734
Operating Income or Loss
-27,885
-36,740
-22,775
-22,164
Interest Expense
-
-
0
344
Total Other Income/Expenses Net
-
225
-
0
Income Before Tax
-27,507
-36,367
-22,677
-22,461
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-27,507
-36,367
-22,677
-22,461
Net Income
-27,507
-36,367
-22,677
-22,461
Net Income available to common shareholders
-27,507
-36,367
-22,677
-22,461
Reported EPS
Basic
-
-1.27
-1.00
-1.04
Diluted
-
-1.27
-1.00
-1.04
Weighted average shares outstanding
Basic
-
28,554
22,619
21,544
Diluted
-
28,554
22,619
21,544
EBITDA
-
-36,740
-22,677
-22,117